AbbVie out-licenses Humira patents to Mylan, biosimilar sales five years away in U.S. July 17, 2018 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Cowen sees upside on Restaurant Brands International Back: All Posts Next:Emerge Energy to open new frac sand terminal in western Canada